Clinical Trials Logo

Coronary Occlusion clinical trials

View clinical trials related to Coronary Occlusion.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05713201 Recruiting - Coronary Disease Clinical Trials

Outcomes After PCI of the Aneurysmatic Right Coronary Artery

RIGHT-MARE
Start date: November 1, 2022
Phase:
Study type: Observational

This study aims to evaluate procedural and clinical outcomes of acute coronay syndrome (ACS) patients with aneurysmatic culprit right coronary artery (RCA).

NCT ID: NCT05705973 Recruiting - Clinical trials for Cardiovascular Disease

Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

NAGOMI COMPLEX
Start date: April 25, 2023
Phase:
Study type: Observational [Patient Registry]

The NAGOMI COMPLEX PMCF (Post-Market Clinical Follow-up) study has been designed to expand the knowledge about outcomes with the Ultimaster Nagomi™ sirolimus eluting coronary stent system (Ultimaster Nagomi™) in complex PCI subjects. The features for a complex PCI are based upon subgroup analysis of earlier published studies.

NCT ID: NCT05458999 Recruiting - Anxiety Clinical Trials

Decreasing Patient Anxiety During Revascularization of Chronic Total Coronary Occlusions Using Virtual Reality Glasses.

ReViCTO
Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Percutaneous coronary angioplasty on chronic total occlusions is a complex procedure. The possibility of performing these procedures without anesthesia and sedation avoids the risks associated with anesthesia and sedation, but, on the contrary, subjects the patient to pain and anxiety during the procedure. Virtual reality (VR) has been successfully used in several clinical settings to reduce intra-procedural anxiety. The aim of this clinical trial is to determine whether the use of a VR system in PCI procedures on CTO decreases the level of anxiety and pain during the procedure.

NCT ID: NCT05238103 Recruiting - Clinical trials for Coronary Artery Disease

Impact of a Corrie Cardiac Rehabilitation Program

mTECH-Rehab
Start date: April 3, 2023
Phase: N/A
Study type: Interventional

In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program will improve functional status, cholesterol level, overall cardiovascular health, individual risk factors, quality of life and mental health for patients who have recently been diagnosed with myocardial infarction, received a coronary stent, underwent heart surgery or catheter-based valve replacement, as compared to usual care.

NCT ID: NCT05164796 Recruiting - Clinical trials for Coronary Artery Occlusion

IVUS Analysis for Coronary Obstruction in TAVI

ICARO
Start date: January 20, 2022
Phase: N/A
Study type: Interventional

Observational, prospective, single-arm and multi-center study to assess the safety and feasibility of IVUS imaging in the setting of TAVI and to describe the angiographic and intravascular ultrasound features in patients with coronary arteries deemed at high-risk for coronary artery obstruction following TAVI.

NCT ID: NCT05089864 Recruiting - Coronary Stenosis Clinical Trials

STAR and Deferred Stenting Study

STAR
Start date: November 23, 2021
Phase: N/A
Study type: Interventional

STAR is a minimal-risk pragmatic clinical trial of patients admitted for a CTO-PCI procedure. The overall objective of the STAR Study is to address the current gaps in knowledge regarding use of STAR during CTO-PCI, as a prospective, multi-center study of 150 participants with randomization of timing of staged PCI. Five sites will be selected to participate in STAR from a national network of highly experienced CTO-PCI centers across the United States.

NCT ID: NCT04691778 Recruiting - Clinical trials for Coronary Artery Disease

Coronary CTO PCI Using Antegrade Wiring Strategy With a First-choice Gladius Guidewire (Gladius First)

Gladius First
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The Gladius First trial is designed as a single-centre, open, prospective, randomized clinical trial aimed to assess the efficiency and safety of coronary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) using the antegrade wiring strategy with a first-choice intermediate Gladius guidewire. To this end, consecutive patients referred to CTO PCI with intended primary antegrade wire escalation strategy, will be randomized in a 1:1 fashion to antegrade wiring starting with the Gladius guidewire or antegrade wiring using the standard guidewire escalation strategy.

NCT ID: NCT04604197 Recruiting - Clinical trials for Coronary Artery Disease

ANGiographic Evaluation of Left Main Coronary Artery INtErvention

ANGELINE
Start date: April 16, 2021
Phase: N/A
Study type: Interventional

To assess if an angiographic follow-up at 6 months after Percutaneous Coronary Intervention in Left Main Coronary Artery Disease decrease the composite objective of death, myocardial infarction, and stroke at 36 months.

NCT ID: NCT04542460 Recruiting - Clinical trials for Chronic Total Coronary Occlusion

The Nordic Baltic Chronic Total Occlusion (CTO) Arrhythmia Study

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

In patients with a chronic total coronary occlusion (CTO ), clinically significant arrhythmia seems to be an important and a poorly investigated problem. The arrhythmia prevalence in an all-comer CTO-population is unknown, but in ICD-populations with ischemic heart disease, a CTO may be found in half of patients with life-threatening arrhythmia.The purpose of the CTO-ARRHYTHMIA study, is to investigate the incidence of clinically significant arrhythmias in CTO patients using an implantable loop recorder. Further, the investigators intend to identify predictors for arrhythmias as well as the impact on arrhythmia of optimized pharmacological treatment and revascularization in CTO patients.

NCT ID: NCT04200469 Recruiting - Coronary Occlusion Clinical Trials

Validation Of Quantitative Flow Ratio (QFR) - Derived Virtual Angioplasty

QIMERA-I
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Prospective intervention study to assess the accuracy of the predicted QFR-derived virtual angioplasty compared to hyperaemic and non-hyperaemic pressure-wire derived indexes after PCI, as well as with QFR post-PCI.